2-Methoxy-4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95+%, 250mg

2-Fluoro-5-iodo-4-methylpyridine, 95.0%, 1g

(3R,4S)-tert-Butyl 2-oxo-4-phenyl-3-((triethylsilyl)oxy)azetidine-1-carboxylate, 95.0%, 10g

Ethyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propanoate, 95.0%, 5g

Plan PL S100x/1.25 objective. Working distance 0.33 mm

4-Hydroxy-5-isopropyl-2-methylbenzaldehyde, 95%, 250mg

(R)-1-BOC-4-BENZYL-3-(HYDROXYMETHYL)-5-OXOPIPERAZINE, 97.0%, 250mg

3-Methyl-1-phenyl-1H-pyrazole-5-carboxylic acid, 99.0%, 250mg

2-Methyl-3-(trifluoromethyl)benzonitrile, 95.0%, 25g

2-Bromo-3-hydroxypyridine>98.0%(T)25g

6-Chloropyridine-3-carboxamide, 95.0%, 25g

tert-butyl (2S)-2-[4-(4-iodophenyl)-1H-imidazol-2-yl]pyrrolidine-1-carboxylate, 97%, 100mg

1,3,3-Trimethylbicyclo[2.2.1]heptan-2-ol, 95.0%, 25g